全文获取类型
收费全文 | 1703432篇 |
免费 | 127698篇 |
国内免费 | 33169篇 |
专业分类
耳鼻咽喉 | 23623篇 |
儿科学 | 52496篇 |
妇产科学 | 48665篇 |
基础医学 | 209831篇 |
口腔科学 | 36017篇 |
临床医学 | 169869篇 |
内科学 | 293657篇 |
皮肤病学 | 37290篇 |
神经病学 | 132385篇 |
特种医学 | 82717篇 |
外国民族医学 | 307篇 |
外科学 | 275960篇 |
综合类 | 129966篇 |
现状与发展 | 230篇 |
一般理论 | 439篇 |
预防医学 | 82747篇 |
眼科学 | 36290篇 |
药学 | 101470篇 |
961篇 | |
中国医学 | 12124篇 |
肿瘤学 | 137255篇 |
出版年
2023年 | 33338篇 |
2022年 | 48092篇 |
2021年 | 66523篇 |
2020年 | 64655篇 |
2019年 | 45495篇 |
2018年 | 54063篇 |
2017年 | 49596篇 |
2016年 | 51476篇 |
2015年 | 58514篇 |
2014年 | 102937篇 |
2013年 | 96759篇 |
2012年 | 101673篇 |
2011年 | 104634篇 |
2010年 | 84628篇 |
2009年 | 75321篇 |
2008年 | 69718篇 |
2007年 | 75930篇 |
2006年 | 67498篇 |
2005年 | 58770篇 |
2004年 | 53075篇 |
2003年 | 50983篇 |
2002年 | 47759篇 |
2001年 | 45877篇 |
2000年 | 43381篇 |
1999年 | 39945篇 |
1998年 | 18601篇 |
1997年 | 15440篇 |
1996年 | 13898篇 |
1995年 | 12321篇 |
1994年 | 10469篇 |
1993年 | 9470篇 |
1992年 | 25841篇 |
1991年 | 24817篇 |
1990年 | 23928篇 |
1989年 | 20732篇 |
1988年 | 18900篇 |
1987年 | 9819篇 |
1986年 | 4093篇 |
1985年 | 6052篇 |
1984年 | 6156篇 |
1983年 | 4923篇 |
1982年 | 5047篇 |
1981年 | 4740篇 |
1980年 | 4274篇 |
1979年 | 3815篇 |
1978年 | 3464篇 |
1977年 | 2878篇 |
1976年 | 2779篇 |
1975年 | 2361篇 |
1974年 | 2448篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Georg Prokop Benedikt Wiestler Daniel Hieber Fynn Withake Karoline Mayer Jens Gempt Claire Delbridge Friederike Schmidt-Graf Nicole Pfarr Bruno Märkl Jürgen Schlegel Friederike Liesche-Starnecker 《International journal of cancer. Journal international du cancer》2023,153(9):1658-1670
Intratumor heterogeneity is a main cause of the dismal prognosis of glioblastoma (GBM). Yet, there remains a lack of a uniform assessment of the degree of heterogeneity. With a multiscale approach, we addressed the hypothesis that intratumor heterogeneity exists on different levels comprising traditional regional analyses, but also innovative methods including computer-assisted analysis of tumor morphology combined with epigenomic data. With this aim, 157 biopsies of 37 patients with therapy-naive IDH-wildtype GBM were analyzed regarding the intratumor variance of protein expression of glial marker GFAP, microglia marker Iba1 and proliferation marker Mib1. Hematoxylin and eosin stained slides were evaluated for tumor vascularization. For the estimation of pixel intensity and nuclear profiling, automated analysis was used. Additionally, DNA methylation profiling was conducted separately for the single biopsies. Scoring systems were established to integrate several parameters into one score for the four examined modalities of heterogeneity (regional, cellular, pixel-level and epigenomic). As a result, we could show that heterogeneity was detected in all four modalities. Furthermore, for the regional, cellular and epigenomic level, we confirmed the results of earlier studies stating that a higher degree of heterogeneity is associated with poorer overall survival. To integrate all modalities into one score, we designed a predictor of longer survival, which showed a highly significant separation regarding the OS. In conclusion, multiscale intratumor heterogeneity exists in glioblastoma and its degree has an impact on overall survival. In future studies, the implementation of a broadly feasible heterogeneity index should be considered. 相似文献
92.
93.
94.
《Journal of infection and chemotherapy》2022,28(12):1639-1644
IntroductionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first broke out in Wuhan in December 2019, and has since caused a global pandemic. The efficacy of several drugs has been evaluated, and it is now evident that tocilizumab has a beneficial effect, especially combined with corticosteroids, in patients with Coronavirus Disease 2019 (COVID-19). However, the optimal timing of tocilizumab administration has not yet been established. The goal of the present study was to determine the optimal timing of tocilizumab administration after starting corticosteroid therapy in patients with COVID-19.MethodsWe retrospectively analyzed the clinical characteristics of patients who were hospitalized for COVID-19 and treated with tocilizumab and corticosteroids in our hospital. The patients were divided into concurrent and sequential groups. The concurrent group received tocilizumab ≤24 h after corticosteroids, and the sequential group received tocilizumab >24 h after corticosteroid administration.ResultsThe baseline clinical characteristics of tocilizumab administration were similar between the two groups. White blood cell counts were significantly lower and C-reactive protein levels were significantly higher in the concurrent group than the sequential group. In the concurrent group, tocilizumab administration led to a significant decrease in maximum body temperature. In addition, there were significantly more oxygen-free days in the concurrent group than in the sequential group. However, survival rate was not significantly different between the concurrent and the sequential groups.ConclusionsIn the combination therapy with tocilizumab and corticosteroids, early administration of tocilizumab after starting corticosteroid treatment is effective when treating COVID-19. 相似文献
95.
96.
《Journal of diabetes and its complications》2022,36(9):108265
ObjectiveThere may be gender difference in correlation of diabetes mellitus (DM) and cardiovascular events. We attempt to investigate whether there is gender-heterogeneity in one-year outcomes of atrial fibrillation (AF) patients with DM or not.MethodsPatients who were diagnosed with AF admitted to the emergency departments in the Chinese AF Multicenter Registry study were enrolled. Basic demographics information, initial Blood Pressure and heart rate, medical histories, and treatments of each patient were collected. Follow-up was carried out with a mean duration of one year. The primary endpoint was all-cause mortality and systemic embolism.ResultsA total of 2016 patients were selected from September 2008 and April 2011. All-cause mortality was significantly higher in male AF patients with DM than those without (21.8 % & 13.6 %, P = 0.014). Cox regression analysis showed that there was an interaction between gender and DM for one-year all-cause mortality (P = 0.049). DM was significantly associated with one-year all-cause mortality regardless of univariate analysis (HR = 1.436, 95%CI:1.079–1.911, P = 0.013) or multivariate analysis (HR = 1.418, 95%CI: 1.059–1.899, P = 0.019). For male patients with AF, DM was significantly associated with one-year all-cause mortality (P = 0.048), but not for female patients with AF (P = 0.362).ConclusionDM was independently associated with one-year all-cause mortality in the entire cohort of AF patients. This association was found mainly in male patients with AF, but not in female patients. DM management programs may need to reflect gender difference. 相似文献
97.
98.
99.
100.
目的 探讨桦木酸对大鼠肺纤维化模型肺组织中NF-κB、β-arrestin2表达的影响。方法 15只SPF级雄性SD大鼠分为对照组、模型组、桦木酸组,每组5只。对照组予以单次气管内注射1 mL·kg-1 0.9%生理盐水,模型组和桦木酸组予单次气管内快速注射5 mg·kg-1博来霉素建立大鼠肺纤维化模型。造模1天后,对照组及模型组给予10 mL·kg-1 1%可溶性淀粉溶液,桦木酸组给予50 mg·kg-1的桦木酸悬浮液,持续21天。HE、Masson染色方法观察肺组织病理改变。酶联免疫吸附法(ELISA)检测肺组织匀浆IL-6的水平。免疫组化法检测肺组织中NF-κB、β-arrestin2、IκBα的表达。结果 与对照组相比,模型组肺组织匀浆中IL-6水平升高,NF-κB、β-arrestin2、IκBα蛋白表达均上调(P<0.05)。与模型组相比,桦木酸组肺组织匀浆中IL-6水平降低,肺组织中NF-κB、β-arrestin2、IκBα蛋白表达均下调(P<0.05)。结论 桦木酸可减轻肺部炎症、减慢肺纤维化的发生发展,可能与下调肺组织中NF-κB、β-arrestin2有关。 相似文献